There was no significant difference in PAR-2 expression levels of the primary tumor of the cervix according to any clinical backgrounds: age, clinical and surgical staging, histopathology, lymph node metastasis including the number of metastatic sites and adjuvant therapy (data not shown). Here, F2RL1 is linked to metastatic malignant neoplasm in the lymph nodes.